Maxim Group downgraded BioRestorative Therapies Inc (BRTX) to Hold from Buy on October 6, 2026.
Among one firm active over the past 90 days, zero hold a bullish rating. The consensus price targets from three analysts as of October 30, 2026, have a mean of $306.00, a median of $306.00 and a range of $303.00 to $315.00.
Consensus Q4 FY2026 EPS is -$2.04, with revenue at $395,250. The next earnings report is on November 10, 2026.
